Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rami Komrokji

Showing results (21-30 of 129) with videos related to

Pageof 13
Sort By:
Cancer Journal (Sudbury, Mass.)|May 17, 2023
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid NeoplasmsZhuoer Xie, Evan C Chen, Lourdes M Mendez, et al.
Cancers|August 23, 2020
Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in MyelofibrosisAndrew T Kuykendall, Nathan P Horvat, Garima Pandey, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 27, 2018
Azacitidine Use for Myeloid NeoplasmsRiad El Fakih, Rami Komrokji, Marwan Shaheen, et al.
Cancer|March 8, 2007
Male breast cancer in the veterans affairs population: a comparative analysisZeina A Nahleh, Roopa Srikantiah, Malek Safa, et al.
Cancer Genomics & Proteomics|March 3, 2018
Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center ExperienceMohammad Omar Hussaini, Abu-Sayeef Mirza, Rami Komrokji, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Hemophagocytic Lymphohistiocytosis in Malignant Hematology: Uncommon but Should Not Be Forgotten?Christa Roe, Janice Bennett, Ling Zhang, et al.
Journal of Clinical Pathology|November 28, 2019
Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndromeIbraahim Badaat, Sabbir Mirza, Eric Padron, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Immunosuppressive Therapy: Exploring an Underutilized Treatment Option for Myelodysplastic SyndromeMintallah Haider, Najla Al Ali, Eric Padron, et al.
American Journal of Hematology|March 25, 2015
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptidesJason Brayer, Jeffrey E Lancet, John Powers, et al.
Blood Advances|September 21, 2022
U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromesRami Komrokji, Luis E Aguirre, Najla Al Ali, et al.
Pageof 13

Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Cancer Journal (Sudbury, Mass.)|May 17, 2023
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid NeoplasmsZhuoer Xie, Evan C Chen, Lourdes M Mendez, et al.
Cancers|August 23, 2020
Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in MyelofibrosisAndrew T Kuykendall, Nathan P Horvat, Garima Pandey, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 27, 2018
Azacitidine Use for Myeloid NeoplasmsRiad El Fakih, Rami Komrokji, Marwan Shaheen, et al.
Cancer|March 8, 2007
Male breast cancer in the veterans affairs population: a comparative analysisZeina A Nahleh, Roopa Srikantiah, Malek Safa, et al.
Cancer Genomics & Proteomics|March 3, 2018
Genetic Landscape of Acute Myeloid Leukemia Interrogated by Next-generation Sequencing: A Large Cancer Center ExperienceMohammad Omar Hussaini, Abu-Sayeef Mirza, Rami Komrokji, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Hemophagocytic Lymphohistiocytosis in Malignant Hematology: Uncommon but Should Not Be Forgotten?Christa Roe, Janice Bennett, Ling Zhang, et al.
Journal of Clinical Pathology|November 28, 2019
Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndromeIbraahim Badaat, Sabbir Mirza, Eric Padron, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Immunosuppressive Therapy: Exploring an Underutilized Treatment Option for Myelodysplastic SyndromeMintallah Haider, Najla Al Ali, Eric Padron, et al.
American Journal of Hematology|March 25, 2015
WT1 vaccination in AML and MDS: A pilot trial with synthetic analog peptidesJason Brayer, Jeffrey E Lancet, John Powers, et al.
Blood Advances|September 21, 2022
U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromesRami Komrokji, Luis E Aguirre, Najla Al Ali, et al.
Pageof 13